These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30817892)

  • 1. 3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis.
    Booij TH; Price LS; Danen EHJ
    SLAS Discov; 2019 Jul; 24(6):615-627. PubMed ID: 30817892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Content, Phenotypic Assays and Screens for Compounds Modulating Cellular Processes in Primary Neurons.
    Kepiro M; Varkuti BH; Davis RL
    Methods Enzymol; 2018; 610():219-250. PubMed ID: 30390800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening out irrelevant cell-based models of disease.
    Horvath P; Aulner N; Bickle M; Davies AM; Nery ED; Ebner D; Montoya MC; Östling P; Pietiäinen V; Price LS; Shorte SL; Turcatti G; von Schantz C; Carragher NO
    Nat Rev Drug Discov; 2016 Nov; 15(11):751-769. PubMed ID: 27616293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D cell cultures toward quantitative high-throughput drug screening.
    Wang Y; Jeon H
    Trends Pharmacol Sci; 2022 Jul; 43(7):569-581. PubMed ID: 35504760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
    Costamagna G; Comi GP; Corti S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.
    Martinez NJ; Titus SA; Wagner AK; Simeonov A
    Expert Opin Drug Discov; 2015 Dec; 10(12):1347-61. PubMed ID: 26394277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation of a tumor microenvironment mimicking 3D tumor growth co-culture assay platform to high-content screening.
    Krausz E; de Hoogt R; Gustin E; Cornelissen F; Grand-Perret T; Janssen L; Vloemans N; Wuyts D; Frans S; Axel A; Peeters PJ; Hall B; Cik M
    J Biomol Screen; 2013 Jan; 18(1):54-66. PubMed ID: 22923784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards.
    Mordwinkin NM; Burridge PW; Wu JC
    J Cardiovasc Transl Res; 2013 Feb; 6(1):22-30. PubMed ID: 23229562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery.
    Ekert JE; Deakyne J; Pribul-Allen P; Terry R; Schofield C; Jeong CG; Storey J; Mohamet L; Francis J; Naidoo A; Amador A; Klein JL; Rowan W
    SLAS Discov; 2020 Dec; 25(10):1174-1190. PubMed ID: 32495689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Droplet-Microarray Platform for High-Throughput Screening of Suspension Cells.
    Popova AA; Depew C; Permana KM; Trubitsyn A; Peravali R; Ordiano JÁ; Reischl M; Levkin PA
    SLAS Technol; 2017 Apr; 22(2):163-175. PubMed ID: 28095175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug screening for human genetic diseases using iPSC models.
    Elitt MS; Barbar L; Tesar PJ
    Hum Mol Genet; 2018 Aug; 27(R2):R89-R98. PubMed ID: 29771306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated image analysis for high-content screening and analysis.
    Shariff A; Kangas J; Coelho LP; Quinn S; Murphy RF
    J Biomol Screen; 2010 Aug; 15(7):726-34. PubMed ID: 20488979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Screening Using Normal Cell and Cancer Cell Mixture in an Automated 3D Cell Culture System.
    Carson MC; Xu P; Gildea JJ; Marino CF; Felder RA
    Methods Mol Biol; 2024; 2823():95-108. PubMed ID: 39052216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
    Eglen RM; Randle DH
    Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.
    Engel BJ; Constantinou PE; Sablatura LK; Doty NJ; Carson DD; Farach-Carson MC; Harrington DA; Zarembinski TI
    Adv Healthc Mater; 2015 Aug; 4(11):1664-74. PubMed ID: 26059746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
    Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
    Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
    SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of high content imaging methods for cell death detection in human pluripotent stem cell-derived cardiomyocytes.
    Mioulane M; Foldes G; Ali NN; Schneider MD; Harding SE
    J Cardiovasc Transl Res; 2012 Oct; 5(5):593-604. PubMed ID: 22896035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.
    Eglen RM; Reisine T
    SLAS Technol; 2019 Feb; 24(1):3-17. PubMed ID: 30286296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.